You can purchase these opportunities directly through this portal, or contact exhibits@ashg.org to discuss package pricing!

Annual Meeting advertising and sponsorship options listed in our Sponsorship Gallery are reserved for our current exhibitors.
Year-round advertising is open to all interested companies!

Don't see a booth configuration you like on the floor plan (are you looking for a corner or island somewhere specific)?
Contact exhibits@ashg.org and let us know what spaces you would like to reserve, we'll help you build the perfect booth!

Mawi DNA Technologies

Hayward, CA
United States
http://www.mawidna.com

Booth: 2019

We are a U.S-based company developing unique biosample collection technologies enabling universal sample collection from any population segment including animals, that allows samples to be transported and stored at room temperature. The innovation of our iSWAB™ biosample collection products allow for the release of cells captured from most swabs into a proprietary buffer. iSWAB samples are used for simple or complex applications in multiomics-based analysis and solves the common issue of low recovery, high bacterial content, low-quality DNA, and excessive resampling costs.

Brands: DNA Sample Collection, RNA Sample Collection, Blood Collection Tubes, Whole Cell sample collection

Videos

Press Releases

Dr. Bassam El-Fahmawi Recognized for Excellence in the Field of Medicine (Oct 03, 2022)

Dr. El-Fahmawi channels years of varied experience into his work with Mawi DNA Technologies

HAYWARD, CA, July 7, 2022, Dr. Bassam El-Fahmawi has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

After Dr. El-Fahmawi and his wife experienced a horrifying medical mystery involving their daughter, he was determined to ensure that other parents didn’t have to encounter the same circumstances by dedicating his career to improving medical diagnostics and science. Upon earning a Bachelor of Science in microbiology from Kuwait University in 1988, he began working for his alma mater as a teaching and research assistant while pursuing a Master of Science in medical microbiology and bacteriology. Following his commencement from graduate school in 1990, he became a researcher with the Institute of Science Research and worked as a medical sales representative for Eli Lilly & Co. Dr. El-Fahmawi later gained valuable expertise as a product manager for RAM Pharma, where he developed business plans, marketing strategies and the budget for new product launches, and as a medical lab manager for Prince Fahd Bin Sultan Hospital through which he managed a laboratory with a $1 million budget.

Dr. El-Fahmawi expanded upon his expertise by earning a Doctor of Philosophy in microbiology and biotechnology from the University of Alberta in 2005, where he also expressed a commitment to civic advocacy by serving as president for Michener Park University Family Housing. He honed his business acumen skills through management and marketing positions with such companies as MJS BioLynx/Canada, Agencourt Bioscience, Beckman Coulter Genomics, Corning Life Sciences and Bioneer Inc. Between 2003 and 2014, Dr. El-Fahmawi managed a multi-million dollar automated DNA extraction and sequencing product line with Beckman Coulter Genomics, and established Bioneer’s medical biology business within the United States, while simultaneously developing the technology and business plan for his new venture.

Drawing on years of professional experience, Dr. El-Fahmawi presently excels as Chief Technical Officer and Chief Executive Officer of Mawi DNA Technologies. Since 2014, he developed and commercialized iSWAB, the company’s unique non-invasive sample collection core technology. Dr. El-Fahmawi also built and supported the company’s infrastructure and sales activities, and expanded upon the company’s intellectual property portfolio. He has contributed his wide range of knowledge and expertise to articles in professional journals in areas such as “Separation apparatus and methods of separating magnetic material” and “Exploring Protein-protein interactions.”

To keep in touch with developments affecting his field, Dr. El-Fahmawi aligns himself with the American Society for Microbiology. To commemorate his accomplishments, he was recognized in the 16^th edition of Who’s Who in the World. In a career filled with highlights, he is most proud of inventing innovative technologies for the non-invasive and invasive collection of biological samples for room temperature transport and storage. Looking toward the future, Dr. El-Fahmawi intends to expand the company on an international scale and introduce new products that solve real world problems.

About Marquis Who’s Who^®:

Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America^®, Marquis Who’s Who^® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who’s Who in America^® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis^® publications may be visited at the official Marquis Who’s Who^® website at www.marquiswhoswho.com.

Mawi DNA Technologies Awarded Two ISO Certifications (Oct 03, 2022)

Hayward, CA - February 9, 2022 – Mawi DNA Technologies (Mawi), a leading biosampling collection company, announces it has been awarded the ISO 9001:2015 Quality Management Systems and ISO 13485:2016 Medical Devices Quality Management Systems certifications. Mawi developed and commercialized the iSWAB technology, an innovative system for collection of biosamples.

This internationally recognized standard signifies that Mawi has developed, maintains and continuously improves its business processes. This is accomplished by measuring and comparing business performance to appropriate quality standards.The ISO certificate helps to improve business credibility and authority, as well as the overall efficiency of the business.

“The ISO certification reinforces our quality structure as a company and as a supplier for our valued customers,” said Hanzel Lawas, Mawi’s QMS and Operations Manager. He added that Mawi celebrates this certification as it supports many COVID-19 projects by maintaining an uninterrupted supply of 100% USA-made innovative sample collection technologies.

“Our company has and will continue to use the ISO standard in all processes and in the design and development of new products,” Jerome David, Mawi’s VP of Sales and Marketing added. “The ISO certification ensures that our company meets the Federal Food and Drug Administration’s requirements and is the first major step to complying with European (EU) regulatory standards for obtaining CE Mark certification, which we expect to have by Q2 2022.” Many products require CE marking before they can be sold in the EU.

Mawi’s mission is to uphold sample integrity at room temperature from anywhere in the world enabling true sample diversity across any geography or population segment. At Mawi, The Future of Biosampling is Here™. For more information, visit www.mawidna.com.

Investors:

Jerome David, VP of Sales and Marketing

510-256-5186, j.david@mawidna.com

Mawi DNA Technologies Nabs CE Certification For Sample Collection Product Portfolio (Oct 03, 2022)

Hayward, CA – March 7, 2022 – Mawi DNA Technologies (Mawi), a leader in biosample collection technologies, announces the company received CE Mark and UK MHRA approval for its portfolio of iSWAB non-invasive collection devices. This approval includes Mawi’s HemaSure-OMICS whole blood collection tubes for gDNA, cfDNA, and RNA from the same sample and the NextSWAB 100% injection molded swab.

The CE Certification, internationally recognized, signifies that Mawi’s products conform to European and UK medical device directives. With CE Mark and UK MHRA approval, Mawi is able to commercialize its full range of products in the UK, European Union and all countries recognizing this molecular diagnostic assays standard.

“CE Mark and UK MHRA approvals are significant milestones for Mawi,” said Dr. Bassam El-Fahmawi, CEO of Mawi DNA Technologies. “It allows us to expand the utility and access of our innovative biosample collection technologies from research use only to the in vitro molecular diagnostics market in Europe. “Further, it opens opportunities to collaborate and partner with European companies and organizations to integrate our products into regulated, high-value market segments such as molecular diagnostic testing, clinical trials, and infectious disease surveillance.”

“Receiving the CE Mark and UK MHRA is a great accomplishment for our company,” Hanzel Lawas, QMS and Operations Manager at Mawi, said. “Together with our recent ISO 9001/13485 certification, it reaffirms our conformity with the IVD Medical Device directives and our commitment to deliver high quality products that meet our customer’s expectations and regulatory requirements.”

About Mawi DNA Technologies

Mawi DNA Technologies, founded in 2013, has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. Mawi’s mission is to uphold sample integrity from anywhere in the world at room temperature, enabling true sample diversity across any geography or population segment. At Mawi, The Future of Biosampling is Here™. For more information, visit http://www.mawidna.com.

Investors:

Jerome David, VP of Sales and Marketing

510-256-5186, j.david@mawidna.com

Products

iSWAB-DNA (1200 & 250)

iSWAB™-DNA is used as an oral specimen collection device for the recovery of high-yield human genomic DNA with low bacterial contamination, suitable for complex genomics downstream applications, including qPCR and NGS-based assays.... More Info Less Info

The iSWAB™-DNA device allows for the collection and stabilization of DNA at the point of collection without the need for swab inclusion. Typical yields of between 10-30μg (iSWAB-DNA-1200) and 5-15μg (iSWAB-DNA-250) of DNA with <1% bacterial contamination can be achieved. The gentle collection and lysis chemistry of the alcohol-free iSWAB buffer allows for the recovery of double-stranded, large fragment DNA similar to the genomic DNA generated from blood, making it suitable for complex genomics downstream assays such as microarrays and Next Generation Sequencing. Suitable for all ages, ethnicities, races, and genders. Ideal for: Paternity Testing, Genealogy, Ancestry, Population Studies, and Genomics.

iSWAB™-DNA device for the ambient temperatures collection stabilization, concentration, transport, and storage of Human DNA samples, derived from saliva and buccal cells. Each iSWAB™-DNA-1200 and iSWAB™-DNA-250 collection device consists of a collection tube that is pre-filled with 1 mL, and 600 µL, respectively, of the nontoxic iSWAB™-DNA buffer and fitted with a proprietary insert. The insert is designed to optimize the release of specimens collected with swabs into the gentle lytic buffer for swab-free transport of specimens.

HemaSure-OMICS

HemaSure-OMICS collection tube for the ambient temperature collection, transport, and storage of whole blood, and for the stabilization, and isolation of RNA, genomic DNA, and cell-free DNA for downstream testing.... More Info Less Info

HemaSure-OMICS is a sterile, plastic, single use, prefilled evacuated direct-draw blood collection with stabilization solution. These components serve to transport venous whole blood samples that is designed to protect RNA molecules from degradation by ribonucleases (RNases), prevent induction of gene expression and to use in conjunction with cell-free DNA purification. AVAILABLE IN 3mL, 6mL, & 9mL.

The device is intended to be placed inside a tube holder or an adaptor that contains a needle designed to pierce the tube closure and allow blood to flow into the tube. Once the vein has been penetrated (using a standard blood collection needle or winged infusion), the tube is pushed into the holder, and the blood enters the tube. Once a tube has drawn the appropriate amount of blood as per the fill volume range marked on the HemaSure-OMICS tube label, it is disengaged from the holder and inverted gently10 times to mix the stabilizing additive with the blood. The specimen is then transported to the lab for plasma isolation and extraction of RNA and cfDNA.

iSWAB-RNA-v2

The iSWAB-RNAv2 device allows for the non-invasive collection, concentration, and stabilization of intact buccal cells collected with a cytobrush allowing for real time ambient stabilization of total RNA from the point of collection to processing.... More Info Less Info

The iSWAB-RNAv2 device is a non-invasive technology for the collection, concentration, and stabilization of intact buccal cells or any mammalian cells collected with a swab or cytobrush allowing for real time ambient stabilization of total RNA from the point of collection to processing. The design of the iSWAB collection device allows for the maximum release of collected samples from multiple swabs or brushes into a single device, to achieve a more concentrated sample. Self collection or assisted collection can be achieved in less than 2 minutes and is suitable for all population segments including infants, toddlers, and elderlies.

The iSWAB™-RNA-v2 maintains RNA stability and protects RNA from degradation. The device allows extended shelf life stability (up to 4 weeks at room temp, several years at -20 C and -80 C), reduced processing time, and minimal storage footprint.

iSWAB-Discovery (DSC)

iSWAB™-DSC device for the ambient temperatures collection stabilization, concentration, transport, and storage of Human DNA samples, derived from saliva and buccal cells.... More Info Less Info

The iSWAB™-DSC Collection device is a non-invasive and nontoxic sample collection technology for the collection, stabilization, concentration, transport, and storage of DNA samples. It is a swab-based sampling applicator and is intended to be used for sample collection of buccal cells. The DNA collection device for human use is designed to capture samples producing high yields of double stranded, long fragmented DNA between 2-7μg with <1% bacterial contamination using traditional sampling swabs.

The iSWAB™-DSC collection device is intended for the collection of double-stranded, large fragment DNA at the point of collection without the need for swab inclusion. The gentle collection and lysis chemistry of the nontoxic iSWAB™-DSC buffer allows for recovery of DNA similar to the genomic DNA generated from blood, making it suitable for complex genomics downstream assays such as microarrays, NGS, and Sanger sequencing. The device can be used for ambient temperature (15-30 °C) transport and storage. Ideal for: paternity testing, genealogy, ancestry, population genomics, cancer research, HLA typing, and epidemiology.

Questions or Need Assistance?

A2Z Events Support: exhibitsupport@a2zinc.net or 443-393-2441
For more A2Z Events tips, visit the A2Z Events FAQ.

ASHG Support: exhibits@ashg.org or 301-634-7318
For ASHG exhibitor tips and info, visit the Exhibit pages on the 2022 Annual Meeting website.